Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) Equity Ratio (2023 - 2025)

Onconetix (ONCO) has disclosed Equity Ratio for 2 consecutive years, with 0.66 as the latest value for Q3 2024.

  • On a quarterly basis, Equity Ratio rose 80.46% to 0.66 in Q3 2024 year-over-year; TTM through Sep 2024 was 0.66, a 80.46% increase, with the full-year FY2023 number at 0.02, changed N/A from a year prior.
  • Equity Ratio was 0.66 for Q3 2024 at Onconetix, up from 0.48 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.88 in Q1 2023 to a low of 0.48 in Q2 2024.